Patents by Inventor Elke Butt

Elke Butt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9383363
    Abstract: The invention relates to the use of LASP-1 in a urine sample obtained from a subject for diagnosing and/or grading transitional cell carcinoma. The invention furthermore relates to a method for diagnosing transitional cell carcinoma comprising detecting the presence or absence of LASP-1 in a urine sample obtained from a subject, wherein the presence of LASP-1 above 1 ng/500 ?l urine is indicative for transitional cell carcinoma and a method for grading transitional cell carcinoma comprising determining the level of LASP-1 in a urine sample obtained from a subject, wherein the level of LASP-1 correlates with the grade of the transitional cell carcinoma.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: July 5, 2016
    Assignee: Julius-Maximilians-Universität-Würzburg
    Inventor: Elke Butt
  • Publication number: 20140370530
    Abstract: The invention relates to the use of LASP-1 in a urine sample obtained from a subject for diagnosing and/or grading transitional cell carcinoma. The invention furthermore relates to a method for diagnosing transitional cell carcinoma comprising detecting the presence or absence of LASP-1 in a urine sample obtained from a subject, wherein the presence of LASP-1 above 1 ng/500 ?l urine is indicative for transitional cell carcinoma and a method for grading transitional cell carcinoma comprising determining the level of LASP-1 in a urine sample obtained from a subject, wherein the level of LASP-1 correlates with the grade of the transitional cell carcinoma.
    Type: Application
    Filed: December 6, 2012
    Publication date: December 18, 2014
    Applicant: JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG
    Inventor: Elke Butt
  • Patent number: 5625056
    Abstract: New derivatives of S.sub.P - and R.sub.P -configures cyclic guanosine-3',5'-phosphorothioates and their physiologically and pharmaceutically acceptable salts according to the general formula ##STR1## are cell membrane permeable inhibitors (R.sub.P -isomers) and stimulators (S.sub.P -isomers) of cyclic GMP-dependent protein kinase which are resistant against phosphodiesterase degradation and suitable as ligands for affinity chromatography of cyclic nucleotide-dependent binding proteins.
    Type: Grant
    Filed: August 7, 1995
    Date of Patent: April 29, 1997
    Assignee: BIOLOG Life Science Institute
    Inventors: Hans-Gottfried Genieser, Ulrich Walter, Elke Butt